During the past decade, Leyenburg Ziekenhuis; Internal Medecine conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Leyenburg Ziekenhuis; Internal Medecine" are "Ovarian Cancer" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Leyenburg Ziekenhuis; Internal Medecine" in a lesser frequency.

Most popular intervention types in "Leyenburg Ziekenhuis; Internal Medecine" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "liposomal doxorubicin" (1 trials), "paclitaxel" (1 trials) and "topotecan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Leyenburg Ziekenhuis; Internal Medecine" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Leyenburg Ziekenhuis; Internal Medecine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Leyenburg Ziekenhuis; Internal Medecine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Leyenburg Ziekenhuis; Internal Medecine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".